ClinConnect ClinConnect Logo
Search / Trial NCT05014074

The Dreamer Girls Project: Adaptation of SISTA/SIHLE for HIV/AIDS and Substance Abuse Prevention Among Black Adolescent Girls

Launched by YALE UNIVERSITY · Aug 12, 2021

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Black Adolescent Girls

ClinConnect Summary

The Dreamer Girls Project is a research study aimed at helping Black adolescent girls prevent HIV/AIDS and substance abuse. The study will gather information through focus groups, where girls will talk about their experiences and share their thoughts in a supportive environment. This will help researchers understand the best ways to provide education and support for these important issues.

To be eligible for this study, participants must be Black or African American females aged 13 to 18 years old, live in Paterson, New Jersey, and speak English as their first language. They will need permission from a parent or guardian to participate. If you or someone you know fits this description, taking part in this study would involve sharing experiences in group discussions, which can be a valuable way to connect with others and contribute to a project that aims to make a positive impact on the community.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria
  • 1. Identify as a Black/African American female
  • 2. Be between the ages of 13-18 years old;
  • 3. Consent to being a part of the study (Parent consent and youth assent if under 18 years old);
  • 4. Live in Paterson, New Jersey at the time of the study;
  • 5. English as their first language.
  • Exclusion Criteria
  • 1. not identify as Black/African American only
  • 2. be under the age of 13 or over the age of 18
  • 3. no parental consent provided
  • 4. no youth assent provided
  • 5. does not live in Paterson
  • 6. does not read, speak or write in English
  • 7. is currently pregnant

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

Paterson, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

Ijeoma Opara, PhD

Principal Investigator

Yale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials